Introduction
============

In the mammalian heart, the resting membrane potential of cardiomyocytes is set and stabilized by the inward rectifier potassium current (*I*~K1~; Dhamoon and Jalife, [@B5]). In addition, *I*~K1~ contributes to outward potassium current during the last phase of action potential repolarization. The main molecular determinants of cardiac *I*~K1~ are the K~IR~2.1 and K~IR~2.2 proteins expressed from the *KCNJ2* and *KCNJ12* genes respectively (De Boer et al., [@B3]). Defective inward rectifier current may lead, amongst other features, to lethal cardiac arrhythmias in mice and man such as ventricular arrhythmias and atrial fibrillation (Anumonwo and Lopatin, [@B1]). ECG recording from neonatal mice homozygous for a *KCNJ2* null mutation showed lengthening of RR, PR, and QT intervals and QRS broadening. Furthermore, isolated neonatal cardiomyocytes displayed action potential lengthening and ectopic activity (Zaritsky et al., [@B33]). In contrast, however, null mutation of *KCNJ12* generated no cardiac abnormalities (Zaritsky et al., [@B33]). *KCNJ2* loss of function mutation associated with Andersen--Tawil syndrome 1 regularly, but not in each case, displayed long repolarization times (LQT) and biventricular tachycardias. On the other hand, *KCNJ2* gain of function mutations have been associated with short QT (Priori et al., [@B19]), and atrial fibrillation (Xia et al., [@B30]). Atrial fibrillation was also observed in a mouse model overexpressing *KCNJ2* (Li et al., [@B13]). Finally, *KCNJ2* mutations have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (Vega et al., [@B29]). Affected K~IR~2.1 and K~IR~2.2 functioning may be the result of amino-acid substitutions (Tristani-Firouzi and Etheridge, [@B28]), direct channel block (Rodríguez-Menchaca et al., [@B22]; De Boer et al., [@B4]), or changes in expression regulation (Yang et al., [@B32]).

The dog (*Canis lupus familiaris*, Cf) with chronic complete atrial--ventricular block (cAVB) is a well established model for drug-induced arrhythmia (Thomsen et al., [@B24]). The model acquires its sensitivity and specificity from bradycardia associated volume overload and subsequent cardiac remodeling (Thomsen et al., [@B26]). The latter process translates into modified contractile, structural, and electrical function (Oros et al., [@B18]). As a result of electrical remodeling, the so-called repolarization reserve (Roden, [@B21]; Michael et al., [@B15]) is diminished as evidenced by increased action potential duration and moreover by increased beat-to-beat variation of repolarization (Thomsen et al., [@B25]).

For some species, the molecular basis underlying cardiac electrophysiology, e.g., ion channel, gap junction, and transporter genes and proteins, is well described. However, a functional integration of the individual components to explain a number of electrophysiological phenomena lags behind, despite many decades of research (Coronel, [@B2]). When considering the dog, the amount of electrophysiological studies by far outnumbers those on the molecular make-up of the underlying ion currents. Nevertheless, the canine genes coding for the electrophysiological building blocks are becoming deciphered rapidly; genome project information can be found at <http://www.broadinstitute.org/mammals/dog>. The publication of the dog genome has provided an important additional tool that stimulated molecular research in this model species (Lindblad-Toh et al., [@B14]). However, as algorithm driven gene annotation is improving gradually (Flicek, [@B6]), its results are still often doubtful indicating that experimental confirmation of the genomic structure of the genes of interest is required. To enable our future studies on *KCNJ2* and *KCNJ12* expression regulation in the dog, it is crucial to characterize the molecular structure of the respective genes. Here we have characterized the canine *KCNJ2* and *KCNJ12* gene structures by combining genome project data, RT-PCR, and 5′- and 3′-RACE protocols. We demonstrated that the canine *KCNJ2* gene consists of two exons harboring its open reading frame (ORF) on exon 2. In contrast, we provided experimental evidence that *KCNJ12* is a three exon gene. Its ORF is located on exon 3. No alternative splicing was detected in either heart or brain tissue. We demonstrated that the gene structure is conserved. Canine K~IR~2.2 harbors a peculiar stretch of glycine residues in its carboxy-terminus that is not present in K~IR~2.2 proteins from other species, which did not affect however its expression in cell systems neither its electrophysiological properties.

Materials and Methods
=====================

RT-PCR, 3′- and 5′-RACE
-----------------------

The investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and was approved by the institutional committee for animal experiments. For all sequencing, samples from at least two purpose bred mongrel dogs were used, that harbored no known genetic defects.

Total RNA was isolated from canine ventricular cells or brain cortex tissue using Trizol (Invitrogen, Breda, The Netherlands) according to the manufacturers recommendations. mRNA was reverse transcribed using oligo dT and Superscript 2 (Invitrogen). Primer sequences for PCR are given in Table [1](#T1){ref-type="table"}. Products were analyzed on ethidium-bromide stained 0.7--1.5% agarose gels. PCR products were isolated from gel using QIAquick Gel Extraction kit (Qiagen, Venlo, The Netherlands), cloned in pGEM-T-easy (Promega, Leiden, The Netherlands) and subsequently sequenced.

###### 

**Sequences of primers used in this study, sequences are given in 5′--3′ orientation**.

  -------------------------------------- ----------------------------------------------
  **KCNJ2 PRIMERS**                      
  KCNJ2\#1se                             AGCTGGGTCTTGGGGATTCTGG
  KCNJ2\#2se                             TTGCAGAGCGCACTGGAGCC
  KCNJ2\#3as                             CATCCACCGCCAGCGAATGT
  KCNJ2\#4as                             ACTGGACGTTGCAGTGGCCG
  KCNJ2\#5se                             TCCGAGGAGACTCGCCGTGAAT
  KCNJ2\#6se                             AGCAGAGTGAGCTCTCCTTCGC
  **KCNJ12 PRIMERS**                     
  KCNJ12\#1se                            GCTGCTGCTGACACAGCCTTG
  KCNJ12\#2se                            CGGGGTGTCCAGAGACCTGGGTTC
  KCNJ12\#3se                            GGACCTGGAGACCGACGACTTCG
  KCNJ12\#4se                            GAGCCGCGATGAGGAAGACGAGG
  KCNJ12\#5se                            GGGTTTGAGCAGAATGGGCCTGG
  KCNJ12\#6as                            GATCACCCAGAAGATGATGCC
  KCNJ12\#7as                            GTTGCCGAAGCCGTTGGCACCCGAC
  KCNJ12\#8as                            CCCGCCTGTGTCAGCAGCAGC
  KCNJ12\#9as                            CGATGGTGGTCTGCGTCTCAATGG
  KCNJ12\#10se                           GTGACCGATTCCTCTCCAGCT
  KCNJ12\#11se                           GCAGGAAATGGAAGCTGCTGC
  KCNJ12\#12as                           ACGCTACTGAGTCTGCAACCG
  KCNJ13\#13as                           CCAGGCCCATTCTGCTCAAAC
  **SUPPLIED GENERACER™ PRIMERS USED**   
  GeneRacer™ 5′ RNA primer               CGACUGGAGCACGAGGACACUGACAUGGACUGAAGGAGUAGAAA
  GeneRacer™ Oligo dT primer             GCTGTCAACGATACGCTACGTAACGGCATGACAGTG(T)~24~
  GeneRacer™ 5′ primer                   CGACTGGAGCACGAGGACACTGA
  GeneRacer™ 5′ nested primer            GGACACTGACATGGACTGAAGGAGTA
  GeneRacer™ 3′ primer                   GCTGTCAACGATACGCTACGTAACG
  GeneRacer™ 3′ nested primer            CGCTACGTAACGGCATGACAGTG
  -------------------------------------- ----------------------------------------------

3′- and 5′-rapid amplification of cDNA ends (RACE) was performed on total RNA using GeneRacer™ kit (Invitrogen) according to the manufacturers recommendations. In short, total RNA was dephosphorylated and decapped followed by ligation of GeneRacer™ 5′ RNA primer. Subsequently, reverse transcription was performed using GeneRacer™ Oligo dT primer and Superscript 3. Finally, 5′ and 3′ RACE PCR was performed using KCNJ2 and 12 primers as indicated in the results and discussion section, in combination with primers supplied and recommended by the manufacturer. Sequences of primers used for RACE are depicted in Table [1](#T1){ref-type="table"}. All PCR products were sequenced by the Dye-terminator sequencing method (BigDye^®^, Applied Biosystems, Nieuwerkerk a.d. IJssel, The Netherlands) on a 3730 Genetic Analyzer (Applied Biosystems).

Cloning and expression analysis of *CfKCNJ12*
---------------------------------------------

Complete *CfKCNJ12* coding sequence was amplified as above using primers KCNJ12\#10se and KCNJ12\#12as as first and KCNJ12\#11se and KCNJ12\#13as as nested primers, and cloned in pGEM-T-Easy followed by subcloning in pcDNA3.1 using *Eco*RI. COS-7 cells were transfected with pcDNA--CfKCNJ12 or pcDNA--HsKCNJ12 (human *KCNJ12*) construct using Lipofectamine 2000 (Invitrogen) according to the manufacturers recommendations. Twenty-four hours post-transfection, cells were harvested in lysis buffer \[20 mM HEPES, pH 7.6, 125 mM NaCl, 10% (v/v) glycerol, 1 mM EDTA, 1 mM EGTA, 1 mM Dithiothreitol, 1% (v/v) Triton X-100\]. Subsequently, 20 μg protein lysate was separated by 10% SDS-PAGE and blotted onto nitrocellulose membrane. Blots were blocked with 5% (v/v) fresh chicken egg yolk in TBST \[20 mM Tris--Cl, pH 8.0, 150 mM NaCl, 0.05% (v/v) Tween-20\] for 1 h at room temperature. K~IR~2.2 protein was detected using K~IR~2.1/2 antibody (cat. no. sc-18708, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and Donkey-anti-Goat horseradish peroxidase (cat. no. 705-035-003, Jackson ImmunoResearch, West Grove, PA, USA). Standard ECL procedure was used for final detection (Santa Cruz Biotechnology). Localization studies were performed following transient transfection in HEK293 cells as described previously (Jansen et al., [@B11]).

Patch clamp electrophysiology
-----------------------------

HEK293T cells cultured on glass coverslips were co-transfected with 0.5 μg pcDNA--K~IR~2.2 and 0.5 μg pEGFP1 expression constructs as described aboved. Patch clamp measurements were done using a AxoPatch 200B amplifier controlled by pClamp 9 software (Molecular devices, Sunnyvale, CA, USA). Voltage clamp measurements of whole cell *I*~K1~ were performed by applying 1 s test pulses ranging between −120 and +40 mV, in 10 mV increments, from a holding potential of −40 mV, and with series resistance compensation of at least 70%. Steady state current at the end of the pulse was normalized to cell capacitance and plotted versus test potential (corrected for liquid junction potential). Patch pipettes were made with a Sutter P-2000 puller (Sutter Instrument, Novato, CA, USA) and had resistances of 2--3 MΩ. Extracellular solution for whole cell *I*~K1~ measurements contained (in mmol/L): NaCl 140, KCl 5.4, CaCl~2~ 1, MgCl~2~ 1, glucose 6, NaHCO~3~ 17.5, HEPES 15, pH 7.4/NaOH. Pipette solution contained potassium gluconate 125, KCl 10, HEPES 5, EGTA 5, MgCl~2~ 2, CaCl~2~ 0.6, Na~2~ATP 4, pH 7.20/KOH.

To evaluate the blocking effect of polyamine on K~IR~2.2 channel currents from both human and dog *KCNJ12* genes, we analyzed chord conductance values from *I*--*V* relationship by inside-out patch clamp experiments as previously described (Ishihara and Ehara, [@B9]). The pipette (extracellular) solution contained (mM): 145 KCl, 1 CaCl~2~, and 5 HEPES (pH 7.4 with KOH). The bath (intracellular) solution contained (mM) 125 KCl, 4 EDTA (2K), 7.2 K~2~HPO~4~, and 2.8 KH~2~PO~4~ (pH 7.2 with KOH). Spermine was used in the concentration of 0.1, 1, and 10 μM. Currents were recorded from inside-out membrane patches at room temperature (22°C; De Boer et al., [@B4]). The holding potential was set to 0 mV, and test pulses were applied between −60 and +90 mV in 5 mV steps with −40 mV hyperpolarizing pre-pulse. Current amplitude was measured at 2 s after the onset of the test pulse. For this evaluation, we used the equation *G* = *I*/(*V* − *V*~rev~). In our study, the values of *V*~rev~ measured by a ramp protocol (40 mV/s) were always near 0 mV (between ±2 mV). Conductance values for each test voltage were normalized by the maximum value. Furthermore, we evaluated the time-dependent decay of K~IR~2.2 channel current just after the onset of test pulse. Single exponential fitting of the current was performed by Microcal Origin (ver.8, Microcal Software, Northampton, MA, USA).

Results and Discussion
======================

Mapping of the *KCNJ2* gene
---------------------------

To experimentally map the canine *KCNJ2* gene (Figure [1](#F1){ref-type="fig"}A), we first retrieved the putative *KCNJ2* genomic sequence from chromosome 9 using the canine genome project data (accession number NC_006591). Homology comparison (Vector NTI suite 8, operating on Clustal W algorithm) with the mapped murine *KCNJ2* (Redell and Tempel, [@B20]) indicated putative regions for a first and second exon. Based on these, PCR primers were designed for RT-PCR, 5′- and 3′-RACE (Table [1](#T1){ref-type="table"}). RNA was isolated from canine ventricular cardiomyocytes. RT-PCR using primer KCNJ2\#1se and KCNJ2\#3as designed at the putative exon 1 and exon 2 sequences respectively revealed one single product of approximately 590 bp. Exon/intron boundaries were determined by sequencing of the products and aligned against the genomic DNA sequences. Boundaries were found to conform to consensus exon/intron and intron/exon sites, and high levels of homology were found at the splice sites when compared with mouse and chicken (Figure [1](#F1){ref-type="fig"}C). No additional exons were found in this intron region. No differences with respect to the genome reference sequence were observed.

![**Canine *KCNJ2* genomic structure**. **(A)** Representation of the *KCNJ2* gene indicating lengths of first and second exons, intron and the open reading frame (ORF). Relative position of *KCNJ2* specific primers used for intron/exon mapping, 5′ and 3′ RACE are indicated by numbered box arrows. **(B)** Transcription initiation site (bold and underlined) with upstream (lower case) and downstream exon 1 (upper case) sequences. **(C)** Sequence surrounding exon 1--intron and intron--exon 2 splicing sites of dog, mouse, and chicken *KCNJ2* genes. Hatched bar indicates intron region. Exon 1 and exon 2 sequences are indicated in upper case lettering, intron sequence in lower case. Consensus splicing sequences are indicated above the sites (underlined). **(D)** Four alternative 3′ transcript termini (bold). Exon 2 sequences are indicated in upper case, downstream genomic sequences in lower case. Consensus termination signals are indicated above the sequences (underlined).](fphys-03-00009-g001){#F1}

The transcription initiation site (TIS) was mapped by 5′-RACE using primer KCNJ2\#3as and the nested primer KCNJ2\#4as originated from exon 2. Only a single TIS was obtained in this way (Figure [1](#F1){ref-type="fig"}B). RT-PCR using primer KCNJ2\#2se, located directly upstream of the TIS and KCNJ2\#4as yielded no product. In the mouse *KCNJ2* gene, four TISs were determined located in a stretch of eight nucleotides (Redell and Tempel, [@B20]). In chicken, also four TISs were mapped, of which three are located adjacent to each other, while a fourth was located approximately 20 nucleotides upstream of these (Mutai et al., [@B16]).

For 3′-RACE, nested PCR using KCNJ2\#5se and subsequent KCNJ2\#6se (nested) combined with antisense primers provided by the fabricant was performed. This revealed the presence of four different transcripts (heterogeneity of mRNA cleavage) terminating after two consensus poly (A) signals, namely AAUAAA and AUUAAA (Zhao et al., [@B34]; Figure [1](#F1){ref-type="fig"}D). While for mouse, the transcript was reported to end following the first consensus poly (A) (Redell and Tempel, [@B20]), we found transcript termination only following the second consensus poly (A) site. Heterogenous mRNA cleavage has been noted in approximately 50% of mammalian transcripts with a single poly (A) signal (Tian et al., [@B27]), however its biological significance, if any, is unknown. In the case of *KCNJ2*, heterogenic mRNA cleavage may result from the presence of two poly (A) sites. Furthermore, it has been suggested that the RNA cleavage by the polyadenylation enzyme complex is imprecise in nature (Tian et al., [@B27]). Resulting sequences and annotations can be found at the following GenBank accession numbers: HM209045 for 5′ sequences, HM209046 for 3′ sequences, and BK007085 for complete gene annotation.

When comparing the overall *KCNJ2* structure from dog with those of mouse and chicken (Table [2](#T2){ref-type="table"}) we notice a very similar make-up existing of a short first exon (103--168 bp) containing untranslated mRNA (UTR) only, a large intron varying between \~4900 and \~5500 bp and a large second exon containing the entire ORF. While the length of the second exon is reasonably well conserved between dog and mouse (5268 and 5316 bp respectively), that of the chicken is much shorter (2020 bp). Finally, the gene structure as presented here is not annotated in NCBI Entrez Gene (GeneID 403717, accessed at July 19, 2011), that annotates the coding region only.

###### 

**Comparison of canine *KCNJ2* and *KCNJ12* gene structure with that of other species**.

  ----------------------------------------------------------
             *KCNJ2*\   *KCNJ12*\                   
  ---------- ---------- ----------- -------- ------ --------
  Exon 1     120        168         103      406    \>192

  Intron 1   5163       \~5500      \~4900   1761   n.d.

  Exon 2     5268       \~5316      2020     122    \~123

  Intron 2   n.a.       n.a.        n.a.     6435   n.d.

  Exon 3     n.a.       n.a.        n.a.     1804   \~1883

  ORF        1284       1287        1284     1323   1302

  5′UTR      338        403         319      584    \>369

  3′UTR      3766       \~3800      550      425    \~527
  ----------------------------------------------------------

*Numbers are given in base pairs. ORF, open reading frame; UTR, untranslated region. ^1^Redell and Tempel ([@B20]), ^2^Mutai et al. ([@B16]), ^3^Hugnot et al. ([@B8]), ^4^Ryan et al. ([@B23])*.

Mapping of the *KCNJ12* gene
----------------------------

For mapping *KCNJ12* (Figure [2](#F2){ref-type="fig"}A) experimentally, a similar approach was used as for *KCNJ2*. The putative *KCNJ12* sequence was derived from chromosome 5 (accession number NC_006587). Next, sense (KCNJ12\#1se) and antisense (KCNJ12\#6as) primers were generated within exon 2 (which was then considered as the first exon) and exon 3 sequences, respectively. Subsequent sequencing revealed the exon 2 -- intron 2 -- exon 3 boundaries (Figure [2](#F2){ref-type="fig"}C). Upon 5′RACE using KCNJ12\#7as located in exon 3 and the nested primer KCNJ12\#8as located in exon 2, an additional exon of 406 bps was discovered (Figure [2](#F2){ref-type="fig"}A). Resulting sequences and annotations can be found at GenBank accession numbers HQ378597. RT-PCR using primers located in exon 1 (KCNJ12\#2se) and exon 3 (KCNJ12\#7as for cortex and KCNJ12\#9as for right ventricle) sequences yielded a single product in heart and brain tissue (Figure [3](#F3){ref-type="fig"}A). Upon sequencing, the latter was found as being identical to the ventricular product. No evidence was found for alternative splicing, either by 5′RACE neither by inter-exon RT-PCR. Exon/intron boundaries were determined by sequencing PCR products and compare these to genomic DNA (Figure [2](#F2){ref-type="fig"}C). As for *KCNJ2*, boundaries were found to conform to consensus exon/intron and intron/exon sites. 5′-RACE using primer KCNJ12\#7as and primer KCNJ12\#8as identified one TIS (Figure [2](#F2){ref-type="fig"}B). No putative TATA box was found upstream of the initiation site. 3′-RACE using KCNJ12\#3se and two different nested primers (KCNJ12\#4se and KCNJ12\#5se), all located in exon 3, identified only one termination site (Figure [2](#F2){ref-type="fig"}D). No genuine termination signal was identified in this gene. Finally, no differences with respect to the genome reference sequence were observed.

![**Canine *KCNJ12* genomic structure**. **(A)** Representation of the *KCNJ12* gene indicating lengths of first, second, and third exons, first and second intron, and the open reading frame (ORF). Relative position of *KCNJ12* specific primers used for intron/exon mapping, 5′ and 3′ RACE are indicated by numbered box arrows 1--9. Relative positions of *KCNJ12* specific primers for cloning the ORF are indicated by numbered box arrows 10--13. **(B)** Transcription initiation site (bold and underlined) with upstream (lower case) and downstream exon 1 (upper case) sequences. **(C)** Sequence surrounding exon 1--intron 1, intron 1--exon 2, exon 2--intron 2, and intron 2--exon 3 splicing sites of dog *KCNJ12*. Open bars indicate intron regions, hatched bar indicates exon 2 region. Exon sequences are indicated in upper case lettering, intron sequences in lower case. Consensus splicing sequences are indicated above the sites (underlined). **(D)** 3′ transcript terminus (bold). Exon 3 sequence is indicated in upper case, downstream genomic sequence in lower case. Consensus termination signals are indicated above the sequences (underlined).](fphys-03-00009-g002){#F2}

![**(A)** *KCNJ12* mRNA RT-PCR using primers located in exon 1 and 3 regions yields a single amplification product. Left panel, chronic AV block dog right ventricle; right panel control dog cortex. + Indicates prior RT-reaction, − indicates minus RT control. **(B)** Homology comparison of dog (Cf), human (Hs), guinea pig (Cp), bovine (Bt), rat (Rn), and mouse (Mm) K~IR~2.2 carboxy-termini. Conserved residues are depicted in white font on black background.](fphys-03-00009-g003){#F3}

To our knowledge, no *KCNJ12* gene structure from other species has been published. Indirectly however, Ryan et al. ([@B23]) indicate that the genomic structure of *KCNJ12* is very similar with that of *KCNJ16*. They indicate that *KCNJ12* is a three exon gene with strong homology to *KCNJ16* except for exon 1, which is longer in *KCNJ12* than in *KCNJ16*. *KCNJ12* intron lengths were not reported. When comparing our dog *KCNJ12* sequence with that of human, strong similarity is seen for the length of exon 2 and 3 (Table [2](#T2){ref-type="table"}). Furthermore, dog *KCNJ12* is a three exon gene too, with its entire ORF located on Exon 3. Unfortunately, due to the lack of more specific sequence information of the human form, no reliable comparisons can be made further. Finally, the gene structure as presented here is different from the one that is annotated in NCBI Entrez Gene (GeneID 403760, accessed at July 19, 2011), that annotates the coding region on five separate exons. Furthermore, no 5′ UTR is presented, while the 3′UTR is \~22 bp in length.

Electrophysiological analysis of K~IR~2.2
-----------------------------------------

Translating genomic *KCNJ12* sequence revealed a K~IR~2.2 protein containing a peculiar stretch of glycine residues near the carboxy-terminus. Apparently this was not a sequencing artifact as RT-PCR using primers located in exon 1 and 3 confirmed the finding in mRNA derived from left ventricle and cortex (Figure [3](#F3){ref-type="fig"}A). Although the glycine rich region was not identified in other species (Figure [3](#F3){ref-type="fig"}B), it is found in a less-conserved region of the protein. Glycine rich amino-acid stretches are found in many other proteins, however no function has been addressed. To investigate a potential functional consequence, the complete channel was cloned. Expression in COS-7 cells revealed a protein with an apparent *M*~w~ of \~50 kDa (Figure [4](#F4){ref-type="fig"}A). Upon transfection in HEK293 cells, strong expression of canine K~IR~2.2 was seen at the plasma membrane, comparable with that of human K~IR~2.2 (Figure [4](#F4){ref-type="fig"}B; Kaibara et al., [@B12]). When expressed in HEK293T cells, patch clamp analysis demonstrated the presence of a typical barium sensitive inward rectifying current (Figure [4](#F4){ref-type="fig"}C) which was indistinguishable from human K~IR~2.2 carried *I*~K1~ (Figure [4](#F4){ref-type="fig"}D).

![**Characterization of CfK~IR~2.2**. **(A)** Western blot depicting human (Hs) and dog (Cf) K~IR~2.2 expression upon ectopic expression in COS-7 cells. Non-transfected cells were used as negative control. **(B)** Subcellular localization of ectopic human (Hs) and dog (Cf) K~IR~2.2 in HEK293 cells. **(C)** Current traces of CfK~IR~2.2 carried *I*~K1~, before (control), upon 100 μM BaCl~2~ application (Ba^2+^), and following washout (washout). Horizontal bar: 200 ms; Vertical bar: 2 nA. **(D)** Current--Voltage relationship of dog (Cf, blue squares and line; *n* = 8, average ± SEM) and human (Hs, red circles and line; *n* = 4, average ± SEM) K~IR~2.2 carried *I*~K1~ in HEK293T cells.](fphys-03-00009-g004){#F4}

K~IR~2.x channels show dose-dependent changes of blocking profile by spermine (SPM) and spermidine (Ishihara and Yan, [@B10]). To evaluate the electrophysiological properties of canine K~IR~2.2 into more detail, voltage-dependent blockade of K~IR~2.2 channel current by different concentrations of SPM was analyzed by determining the *V*--*G* relationship (Figures [5](#F5){ref-type="fig"}A,B). The representative current traces measured by inside-out patch clamp show that outward *I*~K1~ currents mediated by human and dog *KCNJ12* are blocked in the presence of 0.1--10 μM of SPM in a dose-dependent manner. The *V*--*G* curve shifted to more negative voltages upon increasing the SPM concentration. No significant difference in *V*--*G* relations at either SPM concentration was observed (Figure [5](#F5){ref-type="fig"}B). In the presence of physiological levels of SPM (1 and 10 μM; Yan et al., [@B31]), human and dog K~IR~2.2 channels displayed similar time-dependent decay at +80 mV \[1 μM: 0.74 ± 0.21 (SEM; *n* = 5) and 0.74 ± 0.15 (*n* = 6) ms; 10 μM: 0.44 ± 0.10 (*n* = 5) and 0.41 ± 0.06 (*n* = 5) ms for human and dog respectively; Figure [5](#F5){ref-type="fig"}C\]. Our results suggested that there is no difference between human and dog K~IR~2.2 with respect to SPM affinity and speed of binding. As the glycine rich domain is not conserved among species and we observed no differences in electrophysiological parameters tested, we speculate that it has no relevance for canine K~IR~2.2 function and its interaction with polyamines.

![**Spermine-induced block of human (Hs) and dog (Cf) K~IR~2.2 channels**. **(A)** Representative traces of K~IR~2.2 channel currents in the absence and presence of 0.1, 1, and 10 μM of spermine. Inset: pulse protocol, currents were elicit by 10 mV step test pulses from −60 to +90 mV. **(B)** Comparison of *V*--*G* relationships of human and dog K~IR~2.2. The scale of *G*/*G*~max~ is logarithmic. Test pulses were applied in 5 mV steps from −60 to +90 mV, and *G* was calculated for each voltage. **(C)** The comparison of time constant of K~IR~2.2 channel currents at +80 mV in the presence of 1 and 10 μM SPM.](fphys-03-00009-g005){#F5}

Only few studies have addressed K~IR~2.2 in ventricular tissue of large animal models, and currently, we can only speculate on the function and significance of canine K~IR~2.2 expression in the heart. Ojaimi et al. ([@B17]) measured expression of left ventricular genes upon transition to pacing induced heart failure in the dog heart. Their data indicate clear expression of both *KCNJ2* and *KCNJ12* in the left ventricle (NCBI gene expression omnibus (GEO) profiles and GDS2424/1582618_at and GDS2424/1582977_at, respectively), however, no change was found upon transition into heart failure. Zobel et al. ([@B35]) report K~IR~2.2 expression in isolated rabbit ventricular myocytes. Upon culturing, expression levels remained whereas K~IR~2.1 expression decreased by 80%. In humans, K~IR~2.2 displayed a more pronounced regional expression than K~IR~2.1, i.e., a preferential expression in the epicardium of the right ventricle compared to the endocardium (Gaborit et al., [@B7]).

Conclusion
==========

We were able to experimentally map the canine *KCNJ2* and *KCNJ12* genes. *KCNJ2* is a two exon gene that displays a similar organization as the mouse homolog, while it differs with the chicken variant in the length of exon 2 only. *KCNJ12* is a three exon gene, which resembles the human organization. No alternative splicing in *KCNJ12* was detected in heart or brain tissue. Canine *KCNJ12* produced genuine K~IR~2.2 carried *I*~K1~ upon expression in HEK293T cells.
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